WASHINGTON–(BUSINESS WIRE)–The results of the 2015 National Institute on Drug Abuse (NIDA) and
University of Michigan’s Monitoring the Future survey released today
found that the percent of teens abuse of over-the-counter (OTC) cough
medicine containing dextromethorphan (DXM) to get high remains at 3
percent. When first reported by Monitoring the Future in 2006, teen OTC
cough medicine abuse was at just under 6 percent.
The Consumer Healthcare Products Association (CHPA) works to reduce
abuse following three strategies: increase teen perception of risk and
social disapproval, increase parent engagement, and limit teen access to
“The results of this year’s Monitoring
the Future survey demonstrate that prevention efforts are essential
to keeping the abuse rate at its all-time low,” CHPA President and CEO
Scott Melville said. “The industry remains committed to helping families
and communities fight this behavior.”
CHPA and Partnership
for Drug-Free Kids work together to reach teens by highlighting the
social disapproval and side effects of cough medicine abuse behaviors.
“It’s gratifying to see DXM abuse remaining at very low levels, and to
feel that the Partnership’s targeted communications efforts, in
collaboration with the Consumer Healthcare Products Association, have
helped teens see this behavior as risky – and pretty embarrassing, too,”
said Sean Clarkin, executive vice president, research and external
relations, Partnership for Drug-Free Kids.
CHPA works to spread the word about the dangers of teen cough medicine
abuse to parents through its Stop
Medicine Abuse campaign.
“Parents have the power to help their teens make good decisions. Through
online engagement with parents, media coverage, and collaboration with
Anti-Drug Coalitions of America, we reached parents and community
leaders more than 279 million times this year,” Melville said.
To restrict teen access to DXM, CHPA supported the passage of state laws
prohibiting the sale of medicines containing DXM to those under 18.
Currently, Arizona, California, Kentucky, Louisiana, New Jersey, New
York, Tennessee, Virginia, and Washington have all passed this
legislation, three of which passed this year thanks to CHPA’s active
engagement. CHPA strongly advocates for passage of national bipartisan
legislation, the DXM Abuse Prevention (DAP) Act of 2015 (H.R. 3250).
CHPA believes the bill is one way to limit teen access to the medicines
and is an important part of prevention along with educating teens about
the risks and mobilizing parents to talk to their teens and safeguard
the medicines in their home.
For more information and resources on preventing teen OTC cough medicine
abuse, visit StopMedicineAbuse.org.
The Consumer Healthcare Products Association (CHPA) is the
134-year-old trade association representing the leading manufacturers
and marketers of over-the-counter (OTC) medicines and dietary
supplements. Every dollar spent by consumers on OTC medicines saves the
U.S. healthcare system $6-$7, contributing a total of $102 billion in
savings each year. CHPA is committed to promoting the increasingly vital
role of over-the-counter medicines and dietary supplements in America’s
healthcare system through science, education, and advocacy.
About CHPA’s Stop
Medicine Abuse Campaign
StopMedicineAbuse.org provides toolkits, brochures, and other
materials at no cost to engage parents and community leaders in the
fight against teen cough medicine abuse.
Moms initiative brings together five moms (a school nurse, a
social marketer, an educator, a community advocate and an author) from
across the country to raise awareness of OTC cough medicine abuse
among parents and to spur them to action – to educate themselves, to
talk with their children, to safeguard their medicines, and to spread
the word to other parents.
Through the Stop Medicine Abuse legislative
action center, parents and other advocates who support a federal
age-18 sales restriction of DXM can send a letter of support for the
DXM Abuse Prevention (DAP) Act of 2015 (H.R. 3250).
CHPA member companies placed a “PARENTS: Learn About Teen Medicine
icon on the packaging of DXM-containing cough medicines. The icon
serves as a mini public service announcement for parents, making them
aware of cough medicine abuse at the point-of-sale and point-of-use
and directing them to StopMedicineAbuse.org resources.
CHPA collaborates with Partnership
for Drug-Free Kids to target teens likely to abuse DXM based on
their online search activity and provide them accurate information
about the consequences of this behavior. For more information, visit WhatIsDXM.com.
Consumer Healthcare Products Association